Over the past several years at Vynamic, we have used our experience and collective knowledge to support successful product launches, for large and small pharma companies, in the US and around the world.
Vynamic has helped to support launch readiness efforts in several global markets.
We’ve Provided Product Launch Support Across Many Therapy Areas:
CVMD
-
Cardiovascular Disease
-
Chronic Kidney Disease
-
Diabetes
-
Lupus Nephritis
Oncology
-
Bladder Cancer
-
Blood Cancer
-
Breast Cancer
-
Chronic Myeloid Leukemia
-
Colorectal Cancer
-
Endometrial Cancer
-
Gastric Cancer
-
GI Cancer
-
Kidney Cancer
-
Liver Cancer
-
Lung Cancer
-
Multiple Myeloma
-
Ovarian Cancer
-
Pancreatic Cancer
-
Prostate Cancer
-
Renal Cancer
Rare Disease
-
Beta Thalassemia
-
Blood Cancer
-
Chronic ITP
-
Dengue Disease
-
Dermatomyositis
-
Endometrial Cancer
-
Eosinophilic Esophagitis
-
Hemochromatosis
-
Hyperkalemic
-
Idiotic Hypersomnia
-
Lung Cancer
-
Multiple Myeloma
-
Myelofibrosis
-
Narcolepsy
-
Ovarian Cancer
-
Short Bowel Syndrome
-
Sickle Cell Disease
-
Spinal Muscular Atrophy
-
Transthyretin (TTR) Amyloidosis
Respiratory
-
Asthma
-
COPD
-
Influenza
-
Respiratory Syncytial Virus
Vaccines
-
HPV Vaccines
-
mRNA Vaccines
-
Pneumococcal Vaccines
Others
-
ADHD
-
Alzheimer’s
-
Chronic Iron Overload
-
Crohn’s Disease
-
Dermatomyositis
-
Dry-Eye Disease
-
Gene Therapy
-
Geographic Atrophy
-
Insomnia
-
Liver Disease
-
Medical Cannabis
-
NASH (Nonalcoholic Steatohepatitis)
-
Ophthalmia
-
Osteoarthritis
-
Osteoporosis
-
Ulcerative Colitis
